Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT00691964. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Compare the efficacy of ABT-874 versus etanercept in subjects with moderate to severe plaque psoriasis
Study identification
- NCT ID
- NCT00691964
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 347 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2008 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Mar 2009 (Actual)
- Last update posted
- Jan 21, 2013
2008 – 2009
United States locations
- U.S. sites
- 35
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 8478 | Tucson | Arizona | 85710 | — |
| Site Reference ID/Investigator# 8462 | Fresno | California | 93720 | — |
| Site Reference ID/Investigator# 8454 | Los Angeles | California | 90045 | — |
| Site Reference ID/Investigator# 8476 | Denver | Colorado | 80209 | — |
| Site Reference ID/Investigator# 9641 | Miami | Florida | 33136 | — |
| Site Reference ID/Investigator# 8463 | Alpharetta | Georgia | 30022 | — |
| Site Reference ID/Investigator# 8479 | Arlington Heights | Illinois | 60005 | — |
| Site Reference ID/Investigator# 8527 | Schaumburg | Illinois | 60194 | — |
| Site Reference ID/Investigator# 9001 | Skokie | Illinois | 60077 | — |
| Site Reference ID/Investigator# 8466 | West Dundee | Illinois | 60118 | — |
| Site Reference ID/Investigator# 8467 | Indianapolis | Indiana | 46256 | — |
| Site Reference ID/Investigator# 8464 | Boston | Massachusetts | 02111 | — |
| Site Reference ID/Investigator# 8459 | St Louis | Missouri | 63117 | — |
| Site Reference ID/Investigator# 8473 | East Windsor | New Jersey | 08520 | — |
| Site Reference ID/Investigator# 8457 | New Brunswick | New Jersey | 08903 | — |
| Site Reference ID/Investigator# 8447 | Albuquerque | New Mexico | 87106 | — |
| Site Reference ID/Investigator# 8475 | New York | New York | 10029-6501 | — |
| Site Reference ID/Investigator# 8468 | Cincinnati | Ohio | 45219 | — |
| Site Reference ID/Investigator# 8460 | Cleveland | Ohio | 44106 | — |
| Site Reference ID/Investigator# 9762 | Oklahoma City | Oklahoma | 73104 | — |
| Site Reference ID/Investigator# 8480 | Lake Oswego | Oregon | 97035 | — |
| Site Reference ID/Investigator# 8469 | Portland | Oregon | 97210 | — |
| Site Reference ID/Investigator# 9566 | Portland | Oregon | 97223 | — |
| Site Reference ID/Investigator# 9761 | Hershey | Pennsylvania | 17033 | — |
| Site Reference ID/Investigator# 8471 | Philadelphia | Pennsylvania | 19103 | — |
| Site Reference ID/Investigator# 8449 | Johnston | Rhode Island | 02919 | — |
| Site Reference ID/Investigator# 8448 | Providence | Rhode Island | 02903 | — |
| Site Reference ID/Investigator# 8456 | Greer | South Carolina | 29651 | — |
| Site Reference ID/Investigator# 8458 | Goodlettsville | Tennessee | 37072 | — |
| Site Reference ID/Investigator# 8461 | Austin | Texas | 78759 | — |
| Site Reference ID/Investigator# 10542 | Dallas | Texas | 75246-1613 | — |
| Site Reference ID/Investigator# 8452 | Houston | Texas | 77030 | — |
| Site Reference ID/Investigator# 8474 | San Antonio | Texas | 78229 | — |
| Site Reference ID/Investigator# 8482 | Tyler | Texas | 75703 | — |
| Site Reference ID/Investigator# 8472 | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00691964, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2013 · Synced Oct 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00691964 live on ClinicalTrials.gov.